A randomised, blinded, placebo-controlled, single ascending dose (SAD) study and multiple ascending dose (MAD) study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a glutamate receptor enhancer in healthy, adult volunteers.
Back to Resource Center